Year: 2025
Type: article
Abstract: Description Purpose This study evaluated caffeine’s effect on EL4 T cell lymphoma proliferation, investigating its potential as a cancer growth modulator. Background: While caffeine is linked to reduced cancer risks, its role in lymphoma is under explored. This study fills a knowledge gap on caffeine’s effects on lymphoma. Methodology: EL4 cells were treated with increasing caffeine concentrations, with controls included. Cell proliferation data, averaged across three trials, was used to assess caffeine’s impact. Key Findings: Contrary to expectations, caffeine exposure led to a dose-dependent increase in EL4 cell proliferation. Higher caffeine concentrations correlated with greater cell density, while untreated controls had the lowest proliferation rates, suggesting a concentration-dependent pro-growth influence. Significance: These findings reveal an unexpected stimulatory effect of caffeine on T-cell lymphoma cells, highlighting the complexity of its actions in cancer. This study underscores the importance of carefully evaluating natural compounds in cancer research, suggesting caffeine may act as a growth modulator in lymphoma, rather than a suppressor. Conclusions Caffeine exposure significantly promotes EL4 cell proliferation, challenging assumptions of its anti-cancer effects. Further investigation is needed to clarify caffeine’s nuanced role in oncological treatment. Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)
Source: The Journal of Immunology
Authors: Bridget Lardie, Adelaide Mendelson, Roberto Aguilar
Language: English
Topic: Coffee research and impacts
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416447447
FWCI:
Cites:
Cited by:
Related to: